Adjusting Therapy Profiles When Switching to Ultra-Rapid Lispro in an Advanced Hybrid Closed-Loop System: An in Silico Study.

Patricio ColmegnaJenny L Diaz CJose Garcia-Tirado Marc D BretonMarc D Breton

Published in: Journal of diabetes science and technology (2022)

Properly adjusting therapy parameters allows to fully leverage glucose control benefits provided by faster insulin analogues, opening opportunities to take another step forward into a next generation of more effective AID solutions.

Keyphrases

molecular docking
type diabetes
metabolic syndrome
glycemic control
blood pressure
skeletal muscle
insulin resistance
mesenchymal stem cells
quantum dots
molecular dynamics simulations